Last updated: Oct 19, 2026, 12:00 AM

Viridian Therapeutics Inc Exchange (NASDAQ, USD)

VRDN

24.09
-0.08 (-0.44%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-13.20%
3 year return (CAGR)
8.97%
5 year return (CAGR)
0.79%
10 year return (CAGR)
-16.44%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
2.06B
Price/Sales
29.02
Ent value
2.33B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open18.04
Daily high18.33
Daily low17.96
Daily Volume2.12M
All-time high1901.25
1y analyst estimate36.75
Beta0.96
EPS (TTM)-3.59
Dividend per share0.00
Ex-div date-
Next earnings date5 Mar 2026

Ready to capitalize on Viridian Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
VRDNS&P500
Current price drop from All-time high-98.73%-1.21%
Highest price drop-99.71%-56.47%
Date of highest drop19 Mar 20209 Mar 2009
Avg drop from high-93.85%-10.65%
Avg time to new high1548 days12 days
Max time to new high3095 days1805 days